Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Shuang Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Genetic clusters related to Type 2 diabetes (T2D) have differential impact on cardiovascular diseases (CVDs), although the underlying mechanisms, such as proteomic perturbation, remain unexplored. We conducted a network Mendelian randomisation (MR) study to identify proteomic mediators linking T2D genetic clusters and CVDs.
Methods
We assessed the associations between genetic liability to T2D and eight genetic clusters ( N = 2 535 601) with 12 CVDs ( N ≤ 1 946 349). For significant pairs, we performed a two‐step MR (mediation) to identify proteins mediating these associations. Inverse‐variance weighted method was the main analysis, with sensitivity analyses including genetic colocalisation. Robustness was evaluated in European‐specific analyses as well as using Olink‐measured proteomic data. False discovery rate (FDR) was used to correct for multiple comparisons.
Results
Obesity cluster was linked to most CVDs (except haemorrhage strokes), with similar patterns for body fat, metabolic syndrome and lipodystrophy clusters. Majority of the protein signals (2739 out of 4907) were related to obesity cluster although glycemia‐related clusters were only associated with a few proteomic signals (≤ 13). Amongst 16 proteins supported by genetic colocalisation (PP H4 > 0.8), the proportion mediated ranged from 1.2% to 36.8%. APOC3, ADH1B, F11 and KLKB1 appeared to be shared across the different genetic clusters, implicating their shared role in CVDs risk. Sensitivity and replication analyses gave similar estimates.
Conclusion
This proteogenomic MR study delineates protein‐mediated pathways linking cluster‐stratified T2D genetic predisposition to cardiovascular risk, which can inform preventive strategies by stratifying individuals based on distinct biological pathways represented by these genetic clusters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
- Department of Population Health, School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong, China.
ORCID-Profile: Gabriel Chun Yin Sung, Shiu Lun Au Yeung
Zitieren
APA
Liao, S., Sung, G. C. Y., Liang, Y., Li, C., & Au Yeung, S. L. (2026). Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71253
Vancouver
Liao S, Sung GCY, Liang Y, Li C, Au Yeung SL. Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71253
BibTeX
@article{Liao2026,
author = {Liao, Shuang and Sung, Gabriel Chun Yin and Liang, Yiwen and Li, Chenxi and Au Yeung, Shiu Lun},
title = {Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71253}
}
EUVIMED